Sierra Capital’s Elevance Health ELV Stock Holding History

Sierra Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-662	Closed	-$244K	–	194
2024 Q4	$244K	Sell	662 -33	-5%	-$13.8K	0.03%	184
2024 Q3	$361K	Hold	695	–	–	0.04%	171
2024 Q2	$377K	Hold	695	–	–	0.05%	159
2024 Q1	$360K	Hold	695	–	–	0.05%	161
2023 Q4	$328K	Sell	695 -9	-1%	-$4.16K	0.05%	156
2023 Q3	$307K	Hold	704	–	–	0.05%	157
2023 Q2	$313K	Hold	704	–	–	0.05%	154
2023 Q1	$324K	Hold	704	–	–	0.05%	153
2022 Q4	$361K	Hold	704	–	–	0.06%	139
2022 Q3	$320K	Sell	704 -14	-2%	-$6.7K	0.06%	145
2022 Q2	$346K	Buy	718 +3	+0.4%	+$1.48K	0.06%	152
2022 Q1	$351K	Buy	715 +11	+2%	+$5.03K	0.06%	157
2021 Q4	$326K	Buy	704 +9	+1%	+$3.79K	0.05%	171
2021 Q3	$259K	Sell	695 -265	-28%	-$101K	0.04%	172
2021 Q2	$367K	Hold	960	–	–	0.07%	137
2021 Q1	$345K	Buy	+960	New	+$309K	0.06%	139

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Sierra Capital's ELV Position: Q1 2025 in Review

Sierra Capital sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 662 shares — an estimated $244K sold.

Sierra Capital first reported a position in ELV in Q1 2021 and held it in 16 quarters. The position peaked at $377K in Q2 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

Sierra Capital reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
Sierra Capital sold 662 Elevance Health shares in Q1 2025, an estimated $244K.
Sierra Capital first reported a position in Elevance Health in Q1 2021 and held it in 16 quarters.
Sierra Capital's Elevance Health position peaked at $377K in Q2 2024.
1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Sierra Capital's 13F filing for Q1 2025, filed 30 Apr 2025.